Pathogenomix granted FDA Breakthrough Device Designation
/PRNewswire/ -- Pathogenomix Inc., a Next Generation Sequencing, pathogen diagnostic company, announced that the US Food and Drug Administration (FDA) has...
United States Paul Robertson Chris Risley Breakthrough Device Program Drug Administration Prnewswire Pathogenomix Inc
Source: prnewswire.com